| Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran S Farajnia, MY Alikhani, R Ghotaslou, B Naghili, A Nakhlband International journal of infectious diseases 13 (2), 140-144, 2009 | 356 | 2009 |
| Yeast expression systems: overview and recent advances R Baghban, S Farajnia, M Rajabibazl, Y Ghasemi, AA Mafi, R Hoseinpoor, ... Molecular Biotechnology 61, 365-384, 2019 | 260 | 2019 |
| Antibody humanization methods–a review and update Y Safdari, S Farajnia, M Asgharzadeh, M Khalili Biotechnology and Genetic Engineering Reviews 29 (2), 175-186, 2013 | 245 | 2013 |
| The critical role of Faecalibacterium prausnitzii in human health: An overview HE Leylabadlo, R Ghotaslou, MM Feizabadi, S Farajnia, SY Moaddab, ... Microbial pathogenesis 149, 104344, 2020 | 199 | 2020 |
| Immunotoxins in cancer therapy: Review and update B Akbari, S Farajnia, S Ahdi Khosroshahi, F Safari, M Yousefi, ... International reviews of immunology 36 (4), 207-219, 2017 | 153 | 2017 |
| High prevalence of metallo-β-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran A Peymani, MR Nahaei, S Farajnia, A Hasani, A Mirsalehian, N Sohrabi, ... Japanese journal of infectious diseases 64 (1), 69-71, 2011 | 139 | 2011 |
| Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action Y Safdari, M Khalili, MA Ebrahimzadeh, Y Yazdani, S Farajnia Pharmacological research 93, 1-10, 2015 | 109 | 2015 |
| Antibody based EpCAM targeted therapy of cancer, review and update S Eyvazi, S Farajnia, S Dastmalchi, F Kanipour, H Zarredar, ... Current Cancer Drug Targets 18 (9), 857-868, 2018 | 107 | 2018 |
| Detection of metallo-β-lactamase–encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran S Yousefi, S Farajnia, MR Nahaei, MT Akhi, R Ghotaslou, MH Soroush, ... Diagnostic microbiology and infectious disease 68 (3), 322-325, 2010 | 102 | 2010 |
| Prevalence and antibiotic resistance patterns of diarrheagenic Escherichia coli isolated from adolescents and adults in Hamedan, Western Iran MY Alikhani, SH Hashemi, MM Aslani, S Farajnia Iranian journal of microbiology 5 (1), 42, 2013 | 101 | 2013 |
| Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran N Sohrabi, S Farajnia, MT Akhi, MR Nahaei, B Naghili, A Peymani, Z Amiri, ... Microbial drug resistance 18 (4), 385-389, 2012 | 91 | 2012 |
| Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial R Mahdavi, N Namazi, M Alizadeh, S Farajnia Food & function 6 (6), 2041-2048, 2015 | 89 | 2015 |
| Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran A PEYMAnI, S FARAJnIA, MR Nahaei, N Sohrabi, L Abbasi, K Ansarin, ... Polish Journal of Microbiology 61 (1), 57-60, 2012 | 89 | 2012 |
| Evolution of phage display technology: from discovery to application L Rahbarnia, S Farajnia, H Babaei, J Majidi, K Veisi, V Ahmadzadeh, ... Journal of drug targeting 25 (3), 216-224, 2017 | 88 | 2017 |
| Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial R Mahdavi, N Namazi, M Alizadeh, S Farajnia Journal of clinical lipidology 10 (5), 1203-1211, 2016 | 88 | 2016 |
| Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates K Aliakbarzade, S Farajnia, AK Nik, F Zarei, A Tanomand Jundishapur journal of microbiology 7 (10), e11924, 2014 | 88 | 2014 |
| Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low‐Calorie Diet in Obese Women: A Randomized, Double‐Blind Controlled Clinical Trial N Namazi, R Mahdavi, M Alizadeh, S Farajnia Phytotherapy Research 29 (11), 1722-1728, 2015 | 85 | 2015 |
| Class 1 integron and imipenem resistance in clinical isolates of Pseudomonas aeruginosa: prevalence and antibiotic susceptibility S Yousefi, MR Nahaei, S Farajnia, M Ghojazadeh, MT Akhi, Y Sharifi, ... Iranian journal of microbiology 2 (3), 115, 2010 | 81 | 2010 |
| Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran S Farajnia, F Azhari, MY Alikhani, MK Hosseini, A Peymani, N Sohrabi Iranian journal of basic medical sciences 16 (6), 751, 2013 | 72 | 2013 |
| Development trends for generation of single-chain antibody fragments S Farajnia, V Ahmadzadeh, A Tanomand, K Veisi, SA Khosroshahi, ... Immunopharmacology and Immunotoxicology 36 (5), 297-308, 2014 | 69 | 2014 |